USD10
SLS Shares
About SELLAS Life Sciences GrSELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
USD10
SLS Shares
About SELLAS Life Sciences GrSELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
Stats
TRADING WINDOW
Open
CLOSES AT
8:00 PM GMT+0
MARKET CAP
$1.49B
OPEN PRICE
$7.90
LOW (1Y)
$1.39
HIGH (1Y)
$9.51
LOW (24H)
$7.53
HIGH (24H)
$8.12
VOLUME (24H)
$4.32M
4.56%
Price history
Time | Price | Change |
|---|---|---|
Today | $7.90 | |
1 Day | $8.11 | |
1 Week | $8.04 | |
1 Month | $7.14 | |
1 Year | $1.61 |
Past performance is not a reliable indicator of future results.
Discover more
Explore other stocks
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.